Literature DB >> 21926087

RAD51 can inhibit PDGF-B-induced gliomagenesis and genomic instability.

Ulrica K Westermark1, Nanna Lindberg, Pernilla Roswall, Daniel Bråsäter, Hildur R Helgadottir, Sanna-Maria Hede, Anders Zetterberg, Maria Jasin, Monica Nistér, Lene Uhrbom.   

Abstract

Faithful replication and DNA repair are vital for maintenance of genome integrity. RAD51 is a central protein in homologous recombination repair and during replication, when it protects and restarts stalled replication forks. Aberrant RAD51 expression occurs in glioma, and high expression has been shown to correlate with prolonged survival. Furthermore, genes involved in DNA damage response (DDR) are mutated or deleted in human glioblastomas, corroborating the importance of proper DNA repair to suppress gliomagenesis. We have analyzed DDR and genomic instability in PDGF-B-induced gliomas and investigated the role of RAD51 in glioma development. We show that PDGF-B-induced gliomas display genomic instability and that co-expression of RAD51 can suppress PDGF-B-induced tumorigenesis and prolong survival. Expression of RAD51 inhibited proliferation and genomic instability of tumor cells independent of Arf status. Our results demonstrate that the RAD51 pathway can prevent glioma initiation and maintain genome integrity of induced tumors, suggesting reactivation of the RAD51 pathway as a potential therapeutic avenue.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21926087      PMCID: PMC3223091          DOI: 10.1093/neuonc/nor131

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  46 in total

1.  Xrcc2 is required for genetic stability, embryonic neurogenesis and viability in mice.

Authors:  B Deans; C S Griffin; M Maconochie; J Thacker
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

Review 2.  Double-strand breaks and tumorigenesis.

Authors:  A J Pierce; J M Stark; F D Araujo; M E Moynahan; M Berwick; M Jasin
Journal:  Trends Cell Biol       Date:  2001-11       Impact factor: 20.808

3.  Targeted inactivation of p53 in human cells does not result in aneuploidy.

Authors:  Fred Bunz; Christine Fauth; Michael R Speicher; Annie Dutriaux; John M Sedivy; Kenneth W Kinzler; Bert Vogelstein; Christoph Lengauer
Journal:  Cancer Res       Date:  2002-02-15       Impact factor: 12.701

4.  RAD51 is involved in repair of damage associated with DNA replication in mammalian cells.

Authors:  Cecilia Lundin; Niklas Schultz; Catherine Arnaudeau; Atul Mohindra; Lasse Tengbjerg Hansen; Thomas Helleday
Journal:  J Mol Biol       Date:  2003-05-02       Impact factor: 5.469

Review 5.  Brain tumours: classification and genes.

Authors:  V P Collins
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-06       Impact factor: 10.154

Review 6.  Genomic instability--an evolving hallmark of cancer.

Authors:  Simona Negrini; Vassilis G Gorgoulis; Thanos D Halazonetis
Journal:  Nat Rev Mol Cell Biol       Date:  2010-03       Impact factor: 94.444

7.  PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.

Authors:  C Dai; J C Celestino; Y Okada; D N Louis; G N Fuller; E C Holland
Journal:  Genes Dev       Date:  2001-08-01       Impact factor: 11.361

8.  Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.

Authors:  Richard A Woo; Randy Y C Poon
Journal:  Genes Dev       Date:  2004-06-01       Impact factor: 11.361

9.  Improved grading of breast adenocarcinomas based on genomic instability.

Authors:  Ulrike Kronenwett; Sören Huwendiek; Carin Ostring; Neil Portwood; Uwe J Roblick; Yudi Pawitan; Ayodele Alaiya; Roland Sennerstam; Anders Zetterberg; Gert Auer
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

10.  Formation of higher-order nuclear Rad51 structures is functionally linked to p21 expression and protection from DNA damage-induced apoptosis.

Authors:  Elke Raderschall; Alex Bazarov; Jiangping Cao; Rudi Lurz; Avril Smith; Wolfgang Mann; Hans-Hilger Ropers; John M Sedivy; Efim I Golub; Eberhard Fritz; Thomas Haaf
Journal:  J Cell Sci       Date:  2002-01-01       Impact factor: 5.285

View more
  8 in total

1.  Overexpression of Golgi phosphoprotein-3 (GOLPH3) in glioblastoma multiforme is associated with worse prognosis.

Authors:  Jinxu Zhou; Tao Xu; Rong Qin; Yong Yan; Chao Chen; Yuanyuan Chen; Hongyu Yu; Chunyan Xia; Yicheng Lu; Xuehua Ding; Yuhai Wang; Xuejian Cai; Juxiang Chen
Journal:  J Neurooncol       Date:  2012-09-13       Impact factor: 4.130

2.  PDGF in gliomas: more than just a growth factor?

Authors:  Nanna Lindberg; Eric C Holland
Journal:  Ups J Med Sci       Date:  2012-02-29       Impact factor: 2.384

Review 3.  Glioblastoma--a moving target.

Authors:  Bengt Westermark
Journal:  Ups J Med Sci       Date:  2012-05       Impact factor: 2.384

Review 4.  PDGF and PDGF receptors in glioma.

Authors:  Inga Nazarenko; Sanna-Maria Hede; Xiaobing He; Anna Hedrén; James Thompson; Mikael S Lindström; Monica Nistér
Journal:  Ups J Med Sci       Date:  2012-04-17       Impact factor: 2.384

5.  Acquisition of meiotic DNA repair regulators maintain genome stability in glioblastoma.

Authors:  M Rivera; Q Wu; P Hamerlik; A B Hjelmeland; S Bao; J N Rich
Journal:  Cell Death Dis       Date:  2015-04-23       Impact factor: 8.469

6.  Lipolytic inhibitor G0S2 modulates glioma stem-like cell radiation response.

Authors:  Yinfang Wang; Yanli Hou; Weiwei Zhang; Angel A Alvarez; Yongrui Bai; Bo Hu; Shi-Yuan Cheng; Kun Yang; Yanxin Li; Haizhong Feng
Journal:  J Exp Clin Cancer Res       Date:  2019-04-05

7.  DNA repair genes in astrocytoma tumorigenesis, progression and therapy resistance.

Authors:  Juliana Ferreira de Sousa; Rodolfo Bortolozo Serafim; Laura Marise de Freitas; Carla Raquel Fontana; Valeria Valente
Journal:  Genet Mol Biol       Date:  2019-12-13       Impact factor: 1.771

8.  Inferring the temporal order of cancer gene mutations in individual tumor samples.

Authors:  Jun Guo; Hanliang Guo; Zhanyi Wang
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.